TrialHIV research & clinical practice2025

Evaluating adherence in an active-controlled HIV pre-exposure prophylaxis trial (PrEPVacc) to inform the estimation of HIV incidence in a counterfactual placebo arm.

Sheila Kansiime et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.